These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9886785)

  • 21. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP; Sharp A; Strom M; Kahl SD
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of protein kinase C by the dihydropyridine calcium channel blocker, felodipine.
    Sutherland C; Walsh MP
    Biochem Pharmacol; 1989 Apr; 38(8):1263-70. PubMed ID: 2706018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of calcium channel blockers on pentylenetetrazol drug discrimination in rats.
    Gatch MB; Wallis CJ; Lal H
    Alcohol; 2001 Apr; 23(3):141-7. PubMed ID: 11435024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of turkey gizzard myosin light chain. Kinase activity by dihydropyridine calcium antagonists.
    Movsesian MA; Swain AL; Adelstein RS
    Biochem Pharmacol; 1984 Dec; 33(23):3759-64. PubMed ID: 6548915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance to the antinociceptive effects of ethanol during ethanol withdrawal.
    Gatch MB
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):946-52. PubMed ID: 16574295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidation of Hantzsch 1,4-dihydropyridines of pharmacological significance by electrogenerated superoxide.
    Ortiz ME; Núñez-Vergara LJ; Camargo C; Squella JA
    Pharm Res; 2004 Mar; 21(3):428-35. PubMed ID: 15070092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine.
    Dolin SJ; Hunter AB; Halsey MJ; Little HJ
    Eur J Pharmacol; 1988 Jul; 152(1-2):19-27. PubMed ID: 2463174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
    Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D
    Chirality; 1990; 2(4):233-40. PubMed ID: 1964575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive mechanism of action and binding sites of nitrendipine.
    Triggle DJ
    Am J Cardiol; 1986 Sep; 58(8):35D-38D. PubMed ID: 2429539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal.
    Whittington MA; Little HJ
    Br J Pharmacol; 1991 Jul; 103(3):1677-84. PubMed ID: 1933131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of a dihydropyridine felodipine-analogue to calmodulin and related calcium-binding proteins.
    Boström SL; Westerlund C; Rochester S; Vogel HJ
    Biochem Pharmacol; 1988 Oct; 37(19):3723-8. PubMed ID: 3178884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH3 cells.
    Cataldi M; Taglialatela M; Palagiano F; Secondo A; de Caprariis P; Amoroso S; di Renzo G; Annunziato L
    Eur J Pharmacol; 1999 Jul; 376(1-2):169-78. PubMed ID: 10440102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin II in normotensive volunteers.
    Sluiter HE; Wetzels JF; Huysmans FT; Koene RA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S154-61. PubMed ID: 2455121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro-in vivo correlation of pharmacodynamics of felodipine in essential hypertensive patients based on an ion-channel binding model.
    Nakajima Y; Yamamoto K; Shimada S; Kotaki H; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Aug; 19(8):1097-9. PubMed ID: 8874826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers.
    Soons PA; Cohen AF; Breimer DD
    Eur J Clin Pharmacol; 1993; 44(2):113-20. PubMed ID: 8453956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel antagonists decrease the ethanol withdrawal syndrome.
    Little HJ; Dolin SJ; Halsey MJ
    Life Sci; 1986 Dec; 39(22):2059-65. PubMed ID: 3784769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of felodipine with calcium-binding proteins.
    Johnson JD; Andrews CT; Khabbaza EJ; Mills JS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S53-9. PubMed ID: 2442519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular profile of oxodipine, a novel dihydropyridine calcium channel blocker, in anesthetized open-chest dogs: a comparison with nitrendipine.
    Alloui A; Talmant JM; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1991; 313():63-75. PubMed ID: 1816765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.